Akèy › Neuropathies sensorielles et autonomes héréditaires › Tennessee › Nashville
Etid klinik pou Neuropathies sensorielles et autonomes héréditaires nan Nashville, TN
6 etid pou Neuropathies sensorielles et autonomes héréditaires ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Study of ACR-2316 in Specific Advanced Solid Tumors
Ap rekriteFaz 1/2
- Tennessee Oncology, Franklin · 17 mi lwen
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- SCRI Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Sarah Cannon Research Institute, Nashville
Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer
Ap rekriteFaz 1/2
- SCRI Oncology Partners, Nashville
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Ap rekriteFaz 1
- Sarah Cannon Cancer Center, Nashville
- Vanderbilt-Ingram Cancer Center, Nashville
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Ap rekriteEtid obsèvasyon
- Sarah Cannon Research Institute, Nashville
Etid Neuropathies sensorielles et autonomes héréditaires nan lòt vil
- Arlington, VA7 etid
- San Antonio, TX7 etid
- Boston, MA6 etid
- New York City, NY6 etid
- Houston, TX5 etid
- Philadelphia, PA5 etid
- Portland, OR4 etid
- Pittsburgh, PA4 etid
- Ann Arbor, MI4 etid
- Washington, DC4 etid
- San Francisco, CA3 etid
- Aurora, CO3 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.